However, their specific role in breast cancer is still poorly understood, even though some of the mediators such as IL-6 and TGF-β1 seem to be clearly involved in progression of breast malignancies into a more malignant phenotype [39, 106, 116]. Here, TGFB1 is linked to breast cancer.